In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1726 News Items found
In Brief
A sign outside the AACR meeting
AACR 2024 Research Highlights From MSK

MSK investigators presented new research on a range of important topics at the 2024 Annual Meeting of the American Association for Cancer Research.
Dana Pe'er
AACR: How Cellular Plasticity Drives Cancer Metastasis

In a plenary presentation at the 2024 American Association for Cancer Research (AACR) Annual Meeting, Dr. Dana Pe’er highlighted three recent research collaborations between her lab and other labs at MSK that have shed new light on the ability of cancer cells to adapt and spread.
Feature
Dr. Andrew Vickers
Myths About PSA Tests and Prostate Cancer Screening

PSA testing is an important part of screening for prostate cancer, when it’s used the right way. Learn the truth dispelling seven myths about the PSA test.
MSK physician-scientist Vinod Balachandran.
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer

Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Andrea Barrio, a breast cancer surgeon at Memorial Sloan Kettering Cancer Center, talks to a patient
Important New Insights into Lymphedema: High Risk, Race, and Ethnicity

Learn about research on lymphedema at Memorial Sloan Kettering Cancer Center, which finds that Black and Hispanic women are at highest risk.
A researcher working in an MSK lab
MSK Research Highlights, March 28, 2024

New MSK research shows the effectiveness of cryoablation for large breast cancer tumors; helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; identifies a gene essential for the formation of a common childhood brain tumor; and unlocks the secrets of natural killer cell metabolism.
Lisa-Erika James, who participates in MSK's Visible Ink, is seen smiling.
The Creativity of People Facing Cancer: Visible Ink Writing Program at MSK

 Fast FactsOver 3,000 people diagnosed with cancer have participated in Visible Ink.The program is free and open to MSK patients of any ageTo join...
Feature
MSK medical physicist Michael Bellamy
6 Myths About Radon and Lung Cancer

Learn about the connection between radon and the risk of lung cancer.
Feature
The Paul Marks Prize medal
The 3 Winners of MSK’s 2023 Paul Marks Prize for Cancer Research Will Present Their Research at Symposium

The three recipients of the 2023 Paul Marks Prize for Cancer Research will present their research at a symposium. Learn about the research of Mark Agnel Frederick Dawson, Cigall Kadoch, and Michelle Monje,
In the Clinic
Man with wife and three sons.
How Robotic Surgery for Colorectal Cancer Can Reduce Side Effects

MSK performs the highest number of robot-assisted surgeries for colorectal cancer in the United States, enabling more patients to have a shorter hospital stay and a faster recovery.